PA
TMO icon

Paragon Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Paragon Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,731
Closed -$2.98M – 91
2024
Q4 		$2.98M Sell
5,731
-41
-0.7% -$22.5K 1.02% 31
2024
Q3 		$3.57M Buy
5,772
+73
+1% +$43.2K 1.16% 26
2024
Q2 		$3.15M Buy
5,699
+546
+11% +$313K 1.15% 28
2024
Q1 		$3M Buy
5,153
+1,115
+28% +$626K 1.21% 25
2023
Q4 		$2.14M Buy
4,038
+138
+4% +$66.8K 0.91% 23
2023
Q3 		$1.97M Sell
3,900
-2,800
-42% -$1.49M 0.82% 29
2023
Q2 		$3.5M Buy
6,700
+1,955
+41% +$1.05M 1.13% 17
2023
Q1 		$2.73M Sell
4,745
-651
-12% -$367K 0.92% 26
2022
Q4 		$2.97M Sell
5,396
-906
-14% -$480K 1.31% 24
2022
Q3 		$3.2M Buy
6,302
+2,465
+64% +$1.38M 1.63% 18
2022
Q2 		$2.08M Sell
3,837
-718
-16% -$395K 1.04% 30
2022
Q1 		$2.69M Buy
4,555
+1,036
+29% +$595K 1.13% 24
2021
Q4 		$2.35M Buy
+3,519
New +$2.2M 1.15% 24

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Paragon Advisors's TMO Position: Q1 2025 in Review

Paragon Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 5,731 shares — an estimated $2.98M sold.

Paragon Advisors first reported a position in TMO in Q4 2021 and held it in 13 quarters. The position peaked at $3.57M in Q3 2024. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Paragon Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Paragon Advisors sold 5,731 Thermo Fisher Scientific shares in Q1 2025, an estimated $2.98M.
  • Paragon Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 13 quarters.
  • Paragon Advisors's Thermo Fisher Scientific position peaked at $3.57M in Q3 2024.
  • 2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Paragon Advisors's 13F filing for Q1 2025, filed 15 Apr 2025.